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1015-9584/Copyright ª 2015, Asian SuSummary Background/Objective: To evaluate the clinical results of patients with infective
endocarditis (IE) complicated by acute cerebrovascular accidents (CVAs).
Methods: A total of 44 patients with IE complicated by CVA at admission were retrospectively
analyzed in a single medical institute from 2005 to 2011. At the time of admission, 18 patients
were diagnosed with hemorrhagic stroke, and 26 patients were diagnosed with ischemic
stroke. Fifteen patients received surgical intervention during hospitalization.
Results: The hospital mortality rate was 38.9% for the hemorrhagic stroke group and 42.3% for
the ischemic stroke group (pZ 0.821). The mortality rate was 33.3% for the surgical group and
44.8% for the nonsurgical group (p Z 0.531). At 30 days of hospitalization, 45.8% of the pa-
tients experienced an adverse event (defined as death due to organ failure, restroke, cardio-
genic shock, or septic shock during the treatment period), and the attrition rate was 1.5% per
day. Surgery performed after the adverse events increased mortality (80.0%) compared with
surgery performed on patients with no adverse events (10.0%; p Z 0.017). A Cox regression
analysis revealed that creatinine > 2 mg/dL, diabetes, and staphylococcal infection were
the risk factors of the adverse events.
Conclusion: Early surgical intervention for IE with ischemic stroke may prevent adverse events,
particularly in patients with impaired renal function, diabetes, or staphylococcal infection. A
delay in operation of > 30 days is recommended after hemorrhagic stroke.
Copyright ª 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved..
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+ MODEL1. IntroductionOver the past decade, infective endocarditis (IE) has caused
significant morbidity and mortality despite the evolution of
antimicrobial therapy and the refinement of surgical tech-
niques.1 Infections involving the valve leaflets, endocar-
dium, chordae, tendineae, and even artificial intracardiac
materials lead to numerous complications, such as valvular
incompetence, embolization, congestive heart failure, and
cerebrovascular accidents. Among the various detrimental
complications, neurologic complications in patients with
endocarditis are the most challenging problems to
address2,3 because of the conflicting nature of their path-
ophysiology (i.e., an embolic event with hemorrhagic
transformation) and the potentially fatal outcome of car-
diac surgery under cardiopulmonary bypass.4 Recent
studies have shown that early surgical intervention may
prevent further complications.4e7 Although emergent sur-
gical indications for IE patients with repeated cerebrovas-
cular accidents (CVAs) have been well established, the
timing of the surgery and its prognostic impact on IE pa-
tients are still controversial. In this study, we analyzed 44
patients with active IE combined with new-onset CVA
admitted to one medical institute over the past 6 years
during hospitalization to evaluate the clinical outcomes and
the complication rate during the waiting period.
2. Methods
Between January 1, 2005, and May 31, 2011, a total of 525
diagnosed IE cases were admitted to one single medical
institute. Among them, 44 patients with active IE and new-
onset CVA for possible surgical intervention were enrolled.
All patients met the modified Duke criteria for definite or
possible endocarditis.8 No patient who was initially
included was excluded from the analyses after the initial
assessment.
2.1. Clinical data
The following clinical and biological parameters were pro-
spectively collected at the time of diagnosis and during
hospitalization: age, gender, comorbidity, diabetes, serum
creatinine level, location of involved valves, pre-existing
prosthetic valve, presence of hemorrhagic stroke, and initial
GlasgowComa Scale (GCS). GCS impairment was defined by a
GCS score7 for thosewith endotracheal intubation or aGCS
score 12 for those without. The diagnosis of CVAwas based
on clinical diagnoses and confirmed through computed to-
mography (CT). CVA was classified as ischemic or hemor-
rhagic according to the initial CT scan. Ischemic stroke was
definedas thepersistenceof a focal neurologic deficit caused
by altered circulation in the cerebral hemispheres, brain
stem, or cerebellum for 24 hours with or without CT or
magnetic resonance imaging (MRI) documentation. Hemor-
rhagic strokes included primary intracerebral hemorrhage,
hemorrhagic infarction, and subarachnoid hemorrhage. Any
hemorrhagic transformation noted during admission was
recorded and placed the patient in the hemorrhagic group.
The diagnosis of CVA was confirmed during the same hospi-
talization period by an experienced neurologist based onPlease cite this article in press as: Hsu C-Y, et al., Clinical experienc
accidents, Asian Journal of Surgery (2015), http://dx.doi.org/10.1016clinical signs or imaging evidence. Transthoracic or trans-
esophageal echocardiography was performed in all cases to
evaluate cardiac function and determine the location of the
involved heart valves. The treatmentwas at the discretion of
the patient’s treating physician. Adverse events included
clinical situations, such as death, restroke, and shock (either
cardiogenic or septic). Death due to chronic CVA sequelae
was counted as “censor” instead of “death.” Restroke was
defined as a new focal neurologic deficit with focal or later-
alizing signs on physical examination and with CT confirma-
tion during admission. Cardiogenic shock was defined as
needing inotropic medication to maintain the mean arterial
pressure above 65 mmHg, oliguria, or lung congestion
requiring an oxygen mask to maintain SaO2 over 90%. Septic
shock was defined as the presence of systemic inflammatory
response syndrome plus signs of end-organ dysfunction. For
patients who had undergone surgery for either ischemic or
hemorrhagic stroke, days to operation were summarized and
compared.
2.2. Statistical analysis
Numeric data were expressed as the mean  standard de-
viation. The frequencies of simple events were reported as
simple percentages. Differences between groups were
compared using Student’s t test, the ManneWhitney U test,
or the Chi-square test according to the data type. Follow-
up events of death and adverse events were analyzed
using a KaplaneMeier survival curve and compared using
Cox regression tests. Variables with p < 0.1 according to
univariate analysis were included in the multivariate anal-
ysis, which was performed with a backward Wald test with
an entry probability of 0.1 and a removal probability of 0.1.
For all statistical evaluations, differences in data with
p < 0.05 were considered significant, and p < 0.1 was
considered a trend. All statistical analyses were performed
using MedCalc version 12 (MedCalc Software, Ostend,
Belgium).
3. Results
A total of 44 patients who met the Duke criteria for IE
combined with CVA at the time of admission were enrolled
in the present study, including 26 patients with ischemic
stroke and 18 patients with hemorrhagic stroke. Three
cases of hemorrhagic transformation were included during
the same admission. All three transformations happened
within 36 hours of admission. The baseline demographic
and clinical characteristics of the patients are summarized
in Table 1. In brief, diabetes was present in 22.2% and 23.1%
of patients in the hemorrhagic and ischemic groups,
respectively (p Z 0.973). Staphylococcal infections were
identified in 38.9% and 34.6% of patients in the hemorrhagic
and ischemic groups, respectively (p Z 0.772).
The clinical outcomes are summarized in Table 2. Adverse
events during hospitalization were also recorded. Restroke
occurred in nine of 44 cases (20.5%), septic shock in seven of
44 cases (15.9%), and cardiogenic shock in two of 44 cases
(11.4%). Operationswere performed for seven patients in the
hemorrhagic group (38.9%) and eight patients in the ischemic
group (30.8%; pZ 0.576). Overall in-hospital mortality wase of infective endocarditis complicated by acute cerebrovascular
/j.asjsur.2015.10.001
Table 1 Baseline demographic and clinical characteristics







Age (y) 54.6  12.1 57.4  19.1 0.484
Male gender 12 (66.7) 16 (61.5) 0.728
Previous prosthetic valve 4 (22.2) 6 (23.1) 0.973
Diabetes 4 (22.2) 6 (23.1) 0.973
Creatinine > 2 mg/dL 2 (11.1) 5 (19.2) 0.469
Aortic valve involved 5 (27.8) 7 (26.9) 0.950
Mitral valve involved 13 (72.2) 19 (73.1) 0.950
Bacteria
Streptococcus 8 (44.4) 8 (30.8) 0.354
Staphylococcus 7 (38.9) 9 (34.6) 0.772
Other G(þ) bacteria 2 (11.1) 0 (0.0) 0.082
G() bacteria 0 (0.0) 3 (11.5) 0.135
Fungus 0 (0.0) 0 (0.0) 1.00
Culture negative 1 (5.6) 6 (23.1) 0.118
GCS impairment 6 (33.3) 7 (26.9) 0.647
Hemiplegia 14 (77.8) 19 (73.1) 0.723
Data in are presented as mean  standard deviation or n (%).
GCS Z Glasgow coma scale; G() Z Gram negative;
G(þ) Z Gram positive.
Table 3 Surgical outcomes of patients according to the






Surgical treatment 7 (38.9) 8 (30.8) d
Time to operation
(d)
32, 33, 59, 60,
63, 121, 165
2, 7, 8, 11, 19,
25, 35, 37
d
Mean  SD (d) 76.1  45.4 18.0  12.4 0.04
Median (d) 60 15 0.04
Post-operation
hospital stay (d)




1 (5.6) 4 (15.4) 0.598
Data are presented as mean  standard deviation (SD) or n (%).
GCS Z Glasgow Coma Scale.
a GCS impairment was defined by a GCS score  7 for those
with endotracheal intubation or a GCS score  12 for those
without.
b Defined as worsening of GCS impairment after operation,
new onset of hemiplegia, or any clinically significant dysfunc-
tion of neurologic performance.
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+ MODELsix (33.3%) in the hemorrhagic group and nine (34.6%) in the
ischemic group. The surgical outcomes are summarized in
Table 3. The number of days to operation was higher in the
hemorrhagic group (32e165 days, median of 60 days) than in
the ischemic group (2e37 days,median of 15 days;pZ 0.04).
The total length of hospital stay was greater in the hemor-
rhagic group (56.0  51.0 days) than in the ischemic group
(25.8  10.3 days; p < 0.01). Neurologic deterioration,
defined as worsening GCS after surgical intervention, new-
onset hemiplegia, or any clinically significant neurologic
deficit, happened post-operatively in one case in the hem-
orrhagic group and in four cases in the ischemic group
(p Z 0.598). No paravalvular leakage or conduction block
was found in the patients after operation. The number of
surgical operations declined mostly because of families’
hesitation about operative or neurological risk.Table 2 Clinical outcomes of patients during hospitali-






Restroke a 4 (22.8) 5 (19.2) 0.890
Cardiogenic shock 2 (11.1) 3 (11.5) 0.661
Septic shock a 3 (16.7) 4 (15.4) 0.909
Received operation 7 (38.9) 8 (30.8) 0.576
Hospital stay (d) 87.6  63.4 54.1  31.2 0.025
Hospital mortality 6 (33.3) 9 (34.6) 0.814
Data are presented as mean  standard deviation or n (%).
a Two patients in the hemorrhagic group and two in the
ischemic group experienced simultaneous restroke and septic
shock, possibly because of multiple septic emboli.
Please cite this article in press as: Hsu C-Y, et al., Clinical experienc
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When the patients were grouped by the occurrence of
adverse events during the 60-day follow up (Figure 1), the
mortality rate was higher among patients who experienced
adverse events (14/19, 73.7%) than among those who did
not (4/25, 16%; p < 0.001). Furthermore, operation per-
formed on survivors after the occurrence of an adverse
event while awaiting surgery was associated with increased
mortality (80.0%) compared to surgery performed on pa-
tients who did not experience adverse events (10.0%;
p Z 0.017).
3.2. Risk factor analysis of the adverse event rate
A KaplaneMeier survival analysis was performed to eval-
uate the rate of adverse events during hospitalization for
the study patients (Figure 2). At 30 days of hospitalization,
54.2% of the patients had not experienced an adverse
event, and the attrition rate was 1.5% per day during the
treatment period. The incidence of adverse events did not
differ significantly between the hemorrhagic and ischemic
groups (p Z 0.287). Univariate analysis (Table 4) revealed
that diabetes [odds ratio (OR) Z 2.65, p Z 0.056],
creatinine > 2 mg/dL (OR Z 3.35, p Z 0.018), and staph-
ylococcal infection (OR Z 2.29, p Z 0.063) were potential
risk factors for adverse events, while age, gender, valve
involvement, prosthetic valve, stroke type, and admission
GCS impairment were not. Multivariate analysis revealed
p Z 0.008 and p Z 0.087 for creatinine > 2 mg/dL and
staphylococcal infection, respectively. For the study group,
diabetes was highly correlated with creatinine > 2 mg/dL,
with a Pearson correlation coefficient of 0.505 (p < 0.001).
We further performed an event-free analysis according
to the presence of staphylococcus infection among the 44
patients (Figure 3). Patients with staphylococcal infectione of infective endocarditis complicated by acute cerebrovascular
/j.asjsur.2015.10.001
Figure 1 60-day outcome of patients grouped by CVA and adverse events. Adverse events are defined as death, restroke,
cardiogenic shock, or septic shock during the treatment period. CVAZ cerebrovascular accident; IEZ infective endocarditis; Op:
open-heart operation.
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At 30 days of hospitalization, 36.4% of the patients in the
staphylococcal infection group had experienced an adverse
event compared with the 64.6% for the non-staphylococcal
infection group (pZ 0.084, trend). The attrition rates were
roughly 2% per day for the staphylococcal group and 1% per
day for the nonstaphylococcal group.
4. Discussion
For the patients with IE and CVA, the adverse event rate
during the first 30 days of hospitalization was high, 1.5% perFigure 2 Proportion of infective endocarditis patients
without adverse events during hospitalization. At 30 days of
hospitalization, 54.2% of the patients had not experienced an
adverse event, and the attrition rate was 1.5% per day during
the treatment period. * p Z 0.287.
Please cite this article in press as: Hsu C-Y, et al., Clinical experienc
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events regardless of whether the patients had received
surgical or medical treatment. Based on these data, we
suggest early surgical intervention for IE with CVA unless
the patient presents with a serious neurological outcome.
According to the available clinical guidelines, prompt
operation after an ischemic stroke and operation within 30
days after a hemorrhagic stroke are recommended to pre-
vent adverse events, particularly for patients with impaired
renal function (creatinine > 2 mg/dL), diabetes, or staph-
ylococcal infection.
IE is still considered a high-risk condition, with overall
mortality rates as high as 20e25%. Hemodynamic deteriora-
tion and central nervous system embolic events are the pri-
mary causes of death.3 Systemic embolism occurs in 22e50%
of patients with IE,9 but the true incidence of acute brain
embolization in left-sided IE may be significantly higher than
indicated by clinical data or CT, as shown by one study.10
According to the current consensus, IE complicated by
acute decompensated congestive heart failure is a well-
established surgical indication.8,11,12 However, contro-
versies have persisted over the past decades in regard to the
surgical intervention of IE with cerebrovascular events,
either ischemic or hemorrhagic. The “treatment dilemma” is
due to the surgery itself. First, previously ischemic blood
vessels are extremely vulnerable to hemorrhagic trans-
formation during anticoagulation therapy, which is required
during a cardiopulmonary bypass to prevent embolus for-
mation in the circuit. Second, tissue perfusion to the brain
may be compromised because of hypotensive episodes dur-
ing cardiac surgery.4 In theearly 1990s, thenotion of delaying
surgery with conservative antibiotic treatment for at least 4
weeks was widely accepted. A multicenter retrospective
study conducted in Japan by Eoshi and colleagues13 sug-
gested that cardiovascular surgery should be postponed to ate of infective endocarditis complicated by acute cerebrovascular
/j.asjsur.2015.10.001
Table 4 Cox regression analysis of adverse events during hospitalization.
Univariate analysis Multivariate analysis
Odds ratio (95% CI) p Odds ratio (95% CI) p
Age (y) 1.01 (0.98e1.04) 0.471 d d
Male gender 0.92 (0.38e2.38) 0.916 d d
Diabetes 2.65 (1.04e6.74) 0.056 d 0.313 a
Creatinine > 2 mg/dL 3.35 (1.33e8.44) 0.018 3.90 (1.42e10.68) 0.008
Aortic valve involved 0.95 (0.34e2.62) 0.922 d d
Double valve involved 0.55 (0.07e4.15) 0.566 d d
Prosthetic IE 1.28 (0.42e3.90) 0.662 d d
Hemorrhagic stroke 0.59 (0.24e1.48) 0.263 d d
GCS impairment 1.65 (0.63e4.36) 0.313 d d
Staphylococcus 2.29 (0.97e5.65) 0.063 2.27 (0.90e5.80) 0.087 b
CI Z confidence interval; GCS Z Glasgow Coma Scale; IE Z infective endocarditis.
a Diabetes was highly correlated with creatinine > 2 mg/dL, with a Pearson correlation coefficient of 0.505 (p < 0.001).
b With a trend.
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+ MODELleast 4 weeks after the onset of cerebral infarction, yet the
progression of cerebral damage is significant and persists
even 4 weeks after a cerebral hemorrhage. Another study,
conducted from 1983 to 1995,14 suggested that valve
replacement should be delayed 2e3 weeks for embolic ce-
rebrovascular events and 4 weeks for embolic cerebrovas-
cular eventswithhemorrhage. Early surgery is recommended
only for certain conditions, including annular or aortic ab-
scesses, heart block, recurrent emboli, resistant infection,
fungal endocarditis, Staphylococcus aureus endocarditis, or
valvular vegetation.8 However, several studies support early
surgical intervention for IE patients. Gammie and col-
leagues15 reported that early mitral valve surgery can be
safely performed for IE cases with silent ischemic stroke
observed using brain CT or MRI. Thuny et al4 also demon-
strated that the risk of postoperative neurologic exacerba-
tion is low for IE cases after a silent cerebral embolism,
transient ischemic attack, or nonmassive ischemic stroke.
Several studies have also reported favorable clinical out-
comes of early surgery for IE patients.7,8,16 A prospective,
randomized study (the Early surgery versus conventionalFigure 3 Proportion of infective endocarditis patients with
and without staphylococcus infection who experienced no
adverse events during hospitalization. * p Z 0.084.
Please cite this article in press as: Hsu C-Y, et al., Clinical experienc
accidents, Asian Journal of Surgery (2015), http://dx.doi.org/10.1016treatment for infective endocarditis (EASE) trial) comparing
the clinical outcomes of early surgery and conventional
treatment for patients with IE demonstrated that early sur-
gery significantly reduces the composite end point of death
from any cause or embolic event by effectively reducing the
risk of systemic embolism.17 The revised 2011 Society of
Thoracic Surgeons Clinical Practice Guidelines3 state that
early surgery performed at < 4 weeks may be reasonable,
particularly in patients with small areas of brain infarction
with a decline in cardiac function, recurrent stroke, or sys-
temic embolism (Class IIb). Otherwise, valve replacement
surgery may be delayed for weeks, unless a second embolic
event occurs despite adequate antibiotic therapy.
The data obtained in the present study indicate that
the most significant difference in prognosis was the
occurrence of adverse events (including restroke,
cardiogenic shock, or septic shock) rather than
hemorrhagic-type or surgical intervention. The mortality
rate greatly increased in patients who had experienced
adverse events compared to the rate in those who had not
(73.7% vs. 16%, respectively; p < 0.001). For patients with
IE and CVA, the present study demonstrates that the
adverse event rate during the first 30 days of hospitali-
zation was high, 1.5% per day. The clinical outcome
deteriorated following an adverse event, and our result
clearly suggests that the operative outcomes became
more serious after the adverse event. Our results are in
accordance with those of previous studies. In another
large prospective cohort study (n Z 291), Thuny et al7
demonstrated that very early surgery (within 1 week)
might be beneficial for patients with the most severe
forms of IE, including S. aureus infection, congestive
heart failure, and large vegetations, to avoid the risk of
in-hospital mortality associated with an increased fre-
quency of relapse and prosthetic valve dysfunction.
However, there is still some built-in diversity and het-
erogeneity in the groups, and that contributes to uncer-
tainty in interpreting the data.
Regarding S. aureus endocarditis, the results suggest
that early surgery is indicated for patients with staphy-
lococcus infection because the adverse event rate was
approximately 2% per day for the staphylococcal infectione of infective endocarditis complicated by acute cerebrovascular
/j.asjsur.2015.10.001
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group (Figure 2). S. aureus endocarditis is characterized
by a rapid onset, high fever, and the frequent involvement
of normal cardiac valves at initial presentation18 and is
associated with a high complication rate.8,19,20 Therefore,
several studies have also recommended early surgery for
IE with an associated staphylococcal infection.21
4.1. Study limitations
The present study suggests a delay in operation of 30 days
for IE with hemorrhagic stroke despite an adverse event
risk of 45%. Due to the limited case number, however, it is
difficult to compare two heterogeneous groups to strongly
demonstrate that early surgery is beneficial for IE patients
with neurologic complication. Furthermore, the surgical
treatment offered is somehow delayed by several vari-
ables, such as treating physician’s discretion and families’
hesitation, and makes the results somewhat confounding
and uncertain. We also noticed three hemorrhagic trans-
formations in the initial ischemic group, which all
happened within 36 hours of admission. By either inter-
vention we could not change the result. Prospective
studies are needed to clarify the impact of early surgery
on patients presenting with IE and a hemorrhagic CVA. It is
hoped that this study will stimulate future research in this
field.
The rate of adverse events after IE with stroke is high, so
early surgical intervention for IE with ischemic stroke may
prevent adverse events, particularly in patients with
impaired renal function, diabetes, or staphylococcal
infection. A delay in operation of > 30 days after hemor-
rhagic stroke is recommended, although the exact timing
for IE with hemorrhagic stroke remains uncertain.
Furthermore, we suggest cardiac echography and brain CT
with angiography be regularly performed during the waiting
period in these unique populations.
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